Blood-based biomarkers for COVID-19

Blood-based biomarkers for COVID-19

June 23, 2020

Establishing biomarkers for COVID-19 that indicate which patients are likely to develop severe disease could help clinicians to categorize patients earlier, improve prognosis and prioritize treatment.
Click here to find out more about Abcam’s SimpleStep ELISA® for blood biomarkers.

BRCA Tumor MASTR Plus Product launch

BRCA Tumor MASTR Plus Product launch

Multiplicom is pleased to announce the release of the BRCA Tumor MASTR Plus molecular assay, research use only, for identification of SNVs in the coding region of BRCA1 and BRCA2 in various types of solid tumors.

June 17, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us